Keith Murphy

This profile gathers the share dealings of Keith Murphy across 2 companies, led by VivoSim Labs, Inc. and TuHURA Biosciences, Inc./NV. Over a trading history stretching from 6 August 2012 to 27 January 2026, the count stands at 34 filings.

Market trades split into 4 purchases (€470k) and 10 sales (€3.8M). No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 19 share grants and 1 option exercise.

A typical purchase (the median) is worth €173k.

Most recently, on 29 January 2026, the filings show a share grant in VivoSim Labs, Inc. The most recent open-market purchase was published on 21 August 2020, 2,254 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.